Kura Oncology (KURA) Prepaid Assets (2010 - 2026)
Kura Oncology (KURA) reported Prepaid Assets of $32.8 million for Q1 2026, up 89.84% year-over-year from $17.3 million in Q1 2025, and up 1.75% on a QoQ basis from $32.2 million in Q4 2025.
Kura Oncology (KURA) has 17 years of Prepaid Assets data on file, last reported at $32.8 million in Q1 2026.
- Quarterly Prepaid Assets rose 89.84% year-over-year to $32.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.8 million (up 89.84% YoY) and the FY2025 annual result came in at $32.2 million, up 109.48% from the prior year.
- Prepaid Assets improved to $32.8 million in Q1 2026 per KURA's latest filing, from $32.2 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $35.1 million in Q3 2025 and bottomed at $7.0 million in Q1 2022.
- The 5-year median for Prepaid Assets is $9.5 million (2022), against an average of $14.9 million.
- The widest annual swing landed in 2023, when Prepaid Assets fell 15.0%; it then jumped 344.27% in 2025.
- Tracing KURA's Prepaid Assets over 5 years: stood at $8.4 million in 2022, then advanced by 0.98% to $8.5 million in 2023, then surged by 80.36% to $15.4 million in 2024, then surged by 109.48% to $32.2 million in 2025, then grew by 1.75% to $32.8 million in 2026.
- Per Business Quant, the three latest KURA Prepaid Assets figures stand at $32.8 million (Q1 2026), $32.2 million (Q4 2025), and $35.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.77 Mn |
| Dec 31, 2025 | 32.21 Mn |
| Sep 30, 2025 | 35.06 Mn |
| Jun 30, 2025 | 24.77 Mn |
| Mar 31, 2025 | 17.26 Mn |
| Dec 31, 2024 | 15.37 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Jun 30, 2024 | 8.25 Mn |
| Mar 31, 2024 | 10.71 Mn |
| Dec 31, 2023 | 8.52 Mn |
| Sep 30, 2023 | 7.32 Mn |
| Jun 30, 2023 | 8.67 Mn |
| Mar 31, 2023 | 10.55 Mn |
| Dec 31, 2022 | 8.44 Mn |
| Sep 30, 2022 | 8.62 Mn |
| Jun 30, 2022 | 9.53 Mn |
| Mar 31, 2022 | 6.96 Mn |
| Dec 31, 2021 | 4.33 Mn |
| Sep 30, 2021 | 5.46 Mn |
| Jun 30, 2021 | 6.14 Mn |
| Mar 31, 2021 | 6.83 Mn |
| Dec 31, 2020 | 3.97 Mn |
| Sep 30, 2020 | 3.50 Mn |
| Jun 30, 2020 | 3.32 Mn |
| Mar 31, 2020 | 4.16 Mn |
| Dec 31, 2019 | 2.71 Mn |
| Sep 30, 2019 | 2.78 Mn |
| Jun 30, 2019 | 2.38 Mn |
| Mar 31, 2019 | 1.88 Mn |
| Dec 31, 2018 | 1.99 Mn |
| Sep 30, 2018 | 2.74 Mn |
| Jun 30, 2018 | 2.42 Mn |
| Mar 31, 2018 | 1.90 Mn |
| Dec 31, 2017 | 1.28 Mn |
| Sep 30, 2017 | 909,000.00 |
| Jun 30, 2017 | 1.19 Mn |
| Mar 31, 2017 | 1.13 Mn |
| Dec 31, 2016 | 725,000.00 |
| Sep 30, 2016 | 886,000.00 |
| Jun 30, 2016 | 1.05 Mn |
| Mar 31, 2016 | 1.20 Mn |
| Dec 31, 2015 | 693,000.00 |
| Sep 30, 2015 | 695,000.00 |
| Jun 30, 2015 | 884,000.00 |
| Mar 31, 2015 | 707,000.00 |
| Dec 31, 2014 | 42,000.00 |
| Mar 31, 2014 | 625.00 |
| Dec 31, 2013 | 2,500.00 |
| Sep 30, 2013 | 4,375.00 |
| Mar 31, 2013 | 1,125.00 |
| Dec 31, 2012 | 3,500.00 |
| Sep 30, 2012 | 5,875.00 |
| Jun 30, 2012 | 6,250.00 |
| Mar 31, 2012 | 625.00 |
| Dec 31, 2011 | 2,500.00 |
| Sep 30, 2011 | 4,375.00 |
| Jun 30, 2011 | 6,250.00 |
| Mar 31, 2011 | 2,500.00 |
| Dec 31, 2010 | 2,500.00 |